MTP - マイダテック・ファ―マ （Midatech Pharma PLC）MTPのニュース
Midatech Pharma reports FY results 2022/04/26 06:46:49 Seeking Alpha
Midatech Pharma press release (MTP): FY Cash and deposits at 31 December 2021 of £10.06M (2020: £7.55M).Net loss from continuing operations of £5.46M (2020: £22.19M loss).Net cash…
Midatech Pharma PLC Announces Results for the Year Ended 31 December 2021 2022/04/26 06:00:00 Wallstreet:Online
ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 26, 2022 / Pharma PLC (AIM:MTPH.L)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, announces its audited preliminary results for the …
Midatech Pharma receives noncompliance notice from Nasdaq 2022/04/14 12:43:10 Seeking Alpha
Midatech Pharma (MTP) received a letter from the Listings Qualifications Department of the Nasdaq that it is not in compliance with the minimum bid price.The notification does not lead…
Midatech Pharma PLC Announces Receipt of NASDAQ Notice 2022/04/14 12:10:00 Wallstreet:Online
ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 14, 2022 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, announces that it received written …
J&J extends R&D collaboration with Midatech Pharma on second molecule (NYSE:JNJ) 2022/03/10 17:10:40 Seeking Alpha
Johnson & Johnson (JNJ) Janssen unit and U.K.-based Midatech Pharma are extending a research collaboration to include a second molecule.
Midatech Pharma moves to new waterside headquarters in Cardiff 2021/09/21 05:58:46 Wales 247
Drug delivery technology company Midatech Pharma plc has moved its Cardiff headquarters to offices in Cardiff Bay. The company has moved to the 1 Caspian Point office building in Caspian Way, Pierhead Street part of the Parmer Cardiff campus on the citys waterfront, where it has created 8,050 sq ft of offices and laboratories on [] The post Midatech Pharma moves to new waterside headquarters in Cardiff appeared first on .
Midatech Pharma plc (MTP) CEO Stephen Stamp on Q2 2021 Results - Earnings Call Transcript 2021/09/20 19:44:05 Seeking Alpha
Midatech Pharma formally opens its new Cardiff headquarters 2021/09/17 06:12:36 Directors Talk
Midatech Pharma PLC (LON:MTPH), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, has announced the formal opening today of its new headquarters, incorporating purpose built laboratory facilities and offices at 1 Caspian Point in Cardiff, UK. The Company has moved to the 1 Caspian Point building, part of the []
Midatech Pharma PLC Announces Notice of Interim Results 2021/09/06 06:32:00 FinanzNachrichten
ABINGDON, OXFORDSHIRE / ACCESSWIRE / September 6, 2021 / Midatech Pharma PLC (AIM:MTPH)(Nasdaq:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of
Midatech Pharma to release its interim results on Friday 17 September 2021 2021/09/06 06:27:07 Directors Talk
Midatech Pharma PLC (LON:MTPH), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, has announced that it will release its interim results for the six months ended 30 June 2021 at 7.00 am BST on Friday 17 September 2021. The Company will be hosting a webinar at 5.30pm BST / []
Midatech Pharma PLC Announces Notice of Interim Results 2021/09/06 06:32:00 FinanzNachrichten
ABINGDON, OXFORDSHIRE / ACCESSWIRE / September 6, 2021 / Midatech Pharma PLC (AIM:MTPH)(Nasdaq:MTP), a drug delivery technology company focused on improving the bio-delivery and biodistribution of
Midatech Pharma to release its interim results on Friday 17 September 2021 2021/09/06 06:27:07 Directors Talk
Midatech Pharma PLC (LON:MTPH), a drug delivery technology company focused on improving the bio-delivery and biodistribution of medicines, has announced that it will release its interim results for the six months ended 30 June 2021 at 7.00 am BST on Friday 17 September 2021. The Company will be hosting a webinar at 5.30pm BST / []
Chemotherapy-Induced Peripheral Neuropathy (CIPN) Market Inclining Growth by 2021-2028| WEX Pharmaceuticals, Asahi Kasei, MediciNova, Achelios Therapeutics, Esteve, ChromaDex, Apollo Endosurgery, Hoffmann-La Roche, Midatech/DARA, Lee''s Pharmaceutical Limi 2021/08/31 06:39:17 OpenPR
Chemotherapy-induced peripheral neuropathy (CIPN) is one of the most frequent side effects caused by antineoplastic agents, with a prevalence from 19% to over 85%. Clinically, CIPN is a mostly sensory neuropathy that may be accompanied by motor and autonomic changes
Somatostatin Analogs Market Report 2021 by Top Key Players: CRINETICS PHARMACEUTICALS, Camurus AB, Midatech Pharma PLC, Dauntless Pharmaceuticals, Ipsen Pharma, Chiasma Inc 2021/07/14 05:02:31 Tramways Monthly
Request Download Sample A new informative report titled as Global Somatostatin Analogs Market Report 2021 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2027 has recently published by Credible Markets to its humongous database which helps to shape the future of the businesses by making well-informed business decisions. It offers a comprehensive analysis []